Patient selection and outcomes in HIPEC for ovarian and peritoneal cancers
Discussion
20m
65 views
Save
Share

Dr. Upasana Palo highlights HIPEC in advanced ovarian cancer, emphasizingoptimal patient selection, interval cytoreduction, and cisplatin-based therapy, supported by OV HIPEC trial evidence for improved survival outcomes.

Join our WhatsApp Channel to get updates. (NOTE: The channel is initially on mute, simply click on the unmute icon to start receiving notifications).

Read more
×
What's Included in Subscription
Become a member & get access to
▪️Exclusive content library ▪️Onference original series ▪️Online mentorship programs ▪️Invite-only hands-on workshops